DEUTSCHE BANK AG\ - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$173,895
-4.5%
21,764
+4.0%
0.00%
Q2 2023$182,125
+148.8%
20,934
-15.9%
0.00%
Q1 2023$73,206
+101.0%
24,900
+139.3%
0.00%
Q4 2022$36,425
-55.0%
10,407
+1.7%
0.00%
Q3 2022$81,000
-13.8%
10,232
-14.6%
0.00%
Q2 2022$94,000
-32.4%
11,975
+4.6%
0.00%
Q1 2022$139,000
-11.5%
11,453
-10.8%
0.00%
Q4 2021$157,000
-93.0%
12,835
-94.0%
0.00%
-100.0%
Q3 2021$2,242,000
+15.7%
215,199
-0.2%
0.00%0.0%
Q2 2021$1,938,000215,5860.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
WOODSTOCK CORP 22,253$514,2670.06%
MASSMUTUAL TRUST CO FSB/ADV 108$2,4960.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders